ASPIRIN; OMEPRAZOLE
| Brand name | YOSPRALA |
|---|---|
| Active ingredient | ASPIRIN; OMEPRAZOLE |
| Strength | 81MG;40MG |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | September 2016 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9539214 | March 2033 | use U-1902 |
| 9987231 | January 2033 | use U-2324 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.